Onyx and Parke-Davis present cell cycle and biochemical effects of PD-0183812 April 6, 2000 No Comments
Novel antitumor agent SJG-136 selected for further preclinical development by NCI April 6, 2000 No Comments
SafeScience's phase II pancreatic cancer trial commences at Beth Israel Deaconess April 6, 2000 No Comments
More news from ACS: Oridigm selects two lead apoptosis-inducing polyamine analogues April 6, 2000 No Comments
Inhibitors of several signal transduction pathways under study at AstraZeneca for cancer, etc. April 6, 2000 No Comments
Ro-31-7453: extensive preclinical and early clinical data presented this week to the AACR April 5, 2000 No Comments
Promising flavonoid discovered by Dutch investigators for preventing doxorubicin cardiotoxicity April 5, 2000 No Comments